Cingulate Inc.

NasdaqCM:CING Stock Report

Market Cap: US$15.4m

Cingulate Management

Management criteria checks 2/4

Cingulate's CEO is Shane Schaffer, appointed in Jan 2012, has a tenure of 12.92 years. total yearly compensation is $629.57K, comprised of 78.1% salary and 21.9% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $827.61. The average tenure of the management team and the board of directors is 6.9 years and 0.8 years respectively.

Key information

Shane Schaffer

Chief executive officer

US$629.6k

Total compensation

CEO salary percentage78.1%
CEO tenure12.9yrs
CEO ownership0.005%
Management average tenure6.9yrs
Board average tenureless than a year

Recent management updates

Recent updates

Here's Why We're A Bit Worried About Cingulate's (NASDAQ:CING) Cash Burn Situation

Aug 26
Here's Why We're A Bit Worried About Cingulate's (NASDAQ:CING) Cash Burn Situation

Cingulate Q2 GAAP EPS of -$0.36

Aug 11

Is Cingulate (NASDAQ:CING) In A Good Position To Deliver On Growth Plans?

Apr 04
Is Cingulate (NASDAQ:CING) In A Good Position To Deliver On Growth Plans?

CEO Compensation Analysis

How has Shane Schaffer's remuneration changed compared to Cingulate's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$19m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$630kUS$492k

-US$24m

Sep 30 2023n/an/a

-US$21m

Jun 30 2023n/an/a

-US$19m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$583kUS$475k

-US$18m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$27m

Mar 31 2022n/an/a

-US$24m

Dec 31 2021US$1mUS$475k

-US$21m

Sep 30 2021n/an/a

-US$19m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$275kUS$275k

-US$7m

Compensation vs Market: Shane's total compensation ($USD629.57K) is about average for companies of similar size in the US market ($USD646.54K).

Compensation vs Earnings: Shane's compensation has increased whilst the company is unprofitable.

CEO

Shane Schaffer (49 yo)

12.9yrs

Tenure

US$629,571

Compensation

Dr. Shane J. Schaffer, PharmD, co-founded Cingulate Inc. in 2012 and since serves as its Chief Executive Officer and Chairman of the Board and served as its Principal Financial Officer since December 13, 2...

Leadership Team

NamePositionTenureCompensationOwnership
Shane Schaffer
CEO & Chairman of the Board12.9yrsUS$629.57k0.0054%
$ 827.6
Laurie Myers
Executive VP & COO6.7yrsUS$476.33k0%
$ 0
Matthew Brams
Executive VP & Chief Medical Officer6.9yrsUS$267.73k0.084%
$ 12.9k
Jennifer Callahan
Senior VPless than a yearno datano data
Raul Silva
Executive VP & Chief Science Officer6.9yrsno datano data
Thomas Dalton
Vice President of Investor & Public Relationsno datano datano data

6.9yrs

Average Tenure

60yo

Average Age

Experienced Management: CING's management team is seasoned and experienced (6.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Shane Schaffer
CEO & Chairman of the Board12.9yrsUS$629.57k0.0054%
$ 827.6
John Roberts
Independent Directorless than a yearno datano data
Bryan Lawrence
Independent Directorless than a yearno datano data
Peter Werth
Director6.5yrsUS$47.94k0.0029%
$ 439.1
Jeffrey Newcorn
Member of Scientific Advisory Boardno datano datano data
Andrew Cutler
Member of Scientific Advisory Boardno datano datano data
Jeffrey S. Ervin
Independent Directorless than a yearno datano data
Ann Childress
Member of Scientific Advisory Boardno datano datano data
Brian Barash
Member of Scientific Advisory Boardno datano datano data
Laurence Greenhill
Member of Scientific Advisory Boardno datano datano data
John Markowitz
Member of Scientific Advisory Boardno datano datano data
Dinohra Munoz-Silva
Member of Scientific Advisory Boardno datano datano data

0.8yrs

Average Tenure

58yo

Average Age

Experienced Board: CING's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 05:54
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cingulate Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Jason McCarthyMaxim Group
Nazibur RahmanMaxim Group